| Israel exports to Japan · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Türkiye · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Heterocyclic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Türkiye · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Sulphonamides | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Vitamins: n.e.s. in item no. 2936.2, and their derivatives, unmixed | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Vitamins: n.e.s. in item no. 2936.2, and their derivatives, unmixed | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Vitamins: n.e.s. in item no. 2936.2, and their derivatives, unmixed | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Vitamins: n.e.s. in heading no. 2936, including natural concentrates | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Hormones and steroids used primarily as hormones: oestrogens and progestogens | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Hormones and steroids used primarily as hormones: (other than insulin and its salts, oestrogens and progestogens) | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Glycosides: natural or reproduced by synthesis, other than rutoside (rutin) and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Glycosides: natural or reproduced by synthesis, other than rutoside (rutin) and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Glycosides: natural or reproduced by synthesis, other than rutoside (rutin) and its derivatives | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Sugars: chemically pure, other than sucrose, lactose, maltose, glucose and fructose: sugar ethers and sugar esters, and their salts, other than products of heading no. 2937, 2938 or 2939 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Antibiotics: n.e.s. in heading no. 2941 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Antibiotics: n.e.s. in heading no. 2941 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Organic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Organic compounds: n.e.s. in chapter 29 | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Glands: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Argentina · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Italy · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Singapore · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Blood: human and animal, antisera and other blood fractions | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Poland · Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Toxins, cultures of micro-organisms (excluding yeasts) and similar products | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Bulgaria · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Chile · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Cyprus · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Denmark · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Finland · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to France · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Germany · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Greece · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Argentina · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to China, Hong Kong SAR · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Hungary · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Australia · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Italy · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Japan · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Austria · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Rep. of Korea · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Lithuania · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Mexico · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Other Asia, nes · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Netherlands · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to New Zealand · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Nigeria · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Norway · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Philippines · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Poland · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Portugal · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Romania · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Russian Federation · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to India · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Singapore · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Slovenia · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Spain · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Sweden · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Switzerland · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Brazil · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Thailand · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Türkiye · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Ukraine · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to United Kingdom · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to USA · Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Canada · Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Chile · Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
| Israel exports to Cyprus · Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | Israel | USD | Annual | 2024-01-01 | CEPII |
Research Data